Welcome to Best Pharmacy at Havmeds! Go shopping!

Product ID: 284211

Reminder: The pictures displayed on this site maybe different from the actual appearance of the product,their maybe a delay in updating the recent picture if their a newly launched packaging from the manufacturer


Zykadia is an orally administered second-generation selective inhibitor of anaplastic lymphoma kinase (ALK). Ceritinib alters downstream signaling pathways and delays the growth of ALK-dependent cancer cells by blocking ALK autophosphorylation.

Trade name
Main ingreadient
150mg*150 tablets
Please discuss the logistics method with the customer service executive on customer service whatsapp/wechat/zalo/viber account
Please follow the doctor’s advice when taking medicines. The mall only guarantees the quality of the medicines and does not provide medical advice.

Authenticity guarantee

India Direct Mail

Privacy packaging

Pharmacy Direct


Zykadia belongs to the class of drugs known as kinase inhibitors. It works by inhibiting the action of an aberrant protein, which prevents cancer cells from growing. Zykadia is a medication used to treat non-small cell lung cancer (NSCLC) caused by an ALK gene mutation (anaplastic lymphoma kinase). It's for persons with advanced non-small-cell lung cancer (NSCLC) whose tumors are positive for anaplastic lymphoma kinase (ALK) by an FDA-approved test.
Zykadia is normally taken once a day with food. Pay strict attention to the dose recommendations provided by your doctor. Store at room temperature, away from moisture. / 150 mg oral capsule; oral tablet (150 mg)
Related Products
Copyright 2023 havmeds.com. All Rights Reserved
Call Us